revealed immune characteristics of local tumor tissues and the systemic environment in patients with CRC by high-dimensional analysis and identified a population of innate lymphocytes (ILCs) with the exclusion of CD4+/CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.